Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Short-Term Debt & Capital Lease Obligation : ¥42 Mil (As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Zhongyuan Union Cell & Gene Engineering Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Zhongyuan Union Cell & Gene Engineering's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥42 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Zhongyuan Union Cell & Gene Engineering's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥66 Mil.

Zhongyuan Union Cell & Gene Engineering Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Zhongyuan Union Cell & Gene Engineering's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongyuan Union Cell & Gene Engineering Short-Term Debt & Capital Lease Obligation Chart

Zhongyuan Union Cell & Gene Engineering Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

31.67

23.00

27.50

29.65

43.75

Zhongyuan Union Cell & Gene Engineering Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial															27.83	34.66	36.03	43.75	42.31

Zhongyuan Union Cell & Gene Engineering Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Zhongyuan Union Cell & Gene Engineering Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Zhongyuan Union Cell & Gene Engineering's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongyuan Union Cell & Gene Engineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhongyuan Union Cell & Gene Engineering Corp Ltd (SHSE:600645) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304

Website

http://www.vcanbio.com

Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.

Executives

Li De Fu	Director
Wang Xue Jun	senior management
Wang Yong	Director
Li Hai Bin	Director
He Wei	senior management
Li Qiang	senior management
Wu Ming Yuan	Director
Wang Hui	Director
Huang Jia Xue	senior management
Cao Hai Feng	Director
Han Yue E	Director
Liu Yong Jun	senior management
Cui Jing Xue	Supervisors
Yang Guang Xing	senior management
Meng Zhi Hong	senior management

Zhongyuan Union Cell & Gene Engineering Headlines

No Headlines